Febe's family was told by doctors there was nothing they could do and to take her home to die, says her emotional son as he relates her story. That all changed when they met Dr. Sylvia Abblitt at World Stem Cells Clinic and received a stem cell treatment. Lutz, FL (PRWEB) February 02, 2013 In the case of Febe, she and her son related the story that Febe was near death with her only option being a feeding tube and oxygen and a slow deteriorate and then a painful death. She was isolated from her family and unable to join in family functions and events then Febe and son said they met an angel named Dr. Sylvia Abblitt at World Stem Cells Clinic and that was the start of a new life for Febe and her family. After the treatment she began to get stronger, had more energy, better skin texture, able to eat food, and her breathing became normal. Not only did it change her interactions with the family but she began to work full time and ran for Mexican congress and her son says she has more energy and act younger than him as he smiles at her. … Continue reading →

BOTHELL, Wash.--(BUSINESS WIRE)-- Seattle Genetics, Inc. (SGEN) today announced that Health Canada has issued a Notice of Compliance with conditions (NOC/c), authorizing marketing of ADCETRIS for two lymphoma indications: (1) the treatment of patients with Hodgkin lymphoma (HL) after failure of autologous stem cell transplant (ASCT) or after failure of at least two multi-agent chemotherapy regimens in patients who are not ASCT candidates, and (2) the treatment of patients with systemic anaplastic large cell lymphoma (sALCL) after failure of at least one multi-agent chemotherapy regimen. The indications for ADCETRIS were authorized based on promising response rates demonstrated in single-arm trials. No data demonstrate increased survival with ADCETRIS. We are focused on making ADCETRIS available globally to all eligible patients with relapsed HL and sALCL. The approval of ADCETRIS in Canada, as well as the recent approval in the European Union, are important milestones to accomplish this goal, said Clay B. Siegall, Ph.D., President and Chief Executive Officer of Seattle Genetics. Now that Health Canada has approved ADCETRIS, we are committed to working closely with public and private insurers to secure reimbursement coverage for patients in Canada. The approval of ADCETRIS in Canada marks a significant milestone for patients with relapsed … Continue reading →

SALINA, Kan. (AP) - A kangaroo at a central Kansas wildlife refuge has undergone a stem cell treatment to repair an injured leg. The Salina Journal reports (http://bit.ly/WDe3ar ) that vets at Rolling Hills Wildlife Adventure performed the procedure Wednesday on the 6-year-old female red kangaroo. The operation was performed by Dr. Danelle Okeson, the zoo's veterinarian, and Dr. Larry Snyder, veterinarian from the University Bird and Small Animal Clinic in Topeka. The procedure was intended to regenerate a damaged joint that was causing the kangaroo to hobble around on one leg and her tail. Snyder says stem cell therapy has been a viable treatment for humans for decades but has only recently been used on animals, mostly house pets and horses. A refuge official says it may take days for zoo officials to notice any improvement. Information from: The Salina (Kan.) Journal, http://www.salina.com Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Read more here: Kan. kangaroo gets stem cell treatment … Continue reading →